Sunshine Lake Pharma Co., Ltd.

North & South Brother Pharmacy Investment Company Limited

Zongyuan Zhang

Zheng Gu

Wuyong Wu

Panpan Kang

Yingjun Zhang

Tong Qu

Pengcho Tang

Gang Chen

Yonggang Wei

Yincai Wang

Heran Wang

Yonghua Lu

Guozhi Zhu

Jiaping Wen

Mingyun Yuan

Weiming Huang

Xiaojun Wang

Xinye Yang

Jianyu Liu

Wanjun Tang

Kangzhi Ye

Guizhuan Su

Zhifu Wan

Chengsheng Lan

Guanpeng Qiu

Chenlu Li

Tianyun Wu

A glucopyranosyl derivative is used as an inhibitor of sodium-dependent glucose transporters (SGLTs), particularly being used as an inhibitor of sodium-dependent glucose transporter-1 (SGLT1), and a pharmaceutically acceptable salt or stereoisomer thereof, further relating to a pharmaceutical composition containing the derivative. The compound and a pharmaceutical composition is used thereof in the preparation of a drug for treating diabetes and diabetes-related diseases.

Glucopyranosyl derivative and use thereof

A glucopyranosyl derivative as a sodium-dependent glucose transporters inhibitor, especially as a SGLT1 inhibitor, a pharmaceutically acceptable salt or a stereoisomer thereof, a pharmaceutical composition thereof, and the uses of the compound and pharmaceutical composition thereof in the preparation of drugs for the treatment of diabetes and diabetes-related diseases.

The present invention relates to a thienopyrimidine derivative and use thereof in medicine, and also to a pharmaceutical composition containing the compound. The compound or pharmaceutical composition is used for inhibiting acetyl-CoA carboxylase (ACC). The present invention also relates to a method of preparing such compound and pharmaceutical composition, as well as their use in the treatment or prevention of diseases regulated by acetyl-CoA carboxylase in mammals, especially in humans.

Thienopyrimidine derivative and use thereof in medicine

This present invention relates to a complex of a glucopyranosyl derivative and L-pyroglutamic acid as a sodium dependent glucose cotransporter (SGLT) inhibitor, and preparation processes thereof, and a pharmaceutical composition containing the complex, and their uses in the manufacture of a medicament for treating diabetes and/or diabetes-related diseases.

Complex of a glucopyranosyl derivative and preparation method and use thereof

The invention relates to hexahydropentaleno derivatives, the preparation method and use in medicine thereof, and in particular to hexahydropentaleno derivatives or stereo-isomers or pharmaceutically acceptable salts thereof as shown in general formula (I), and to the preparation method therefor and pharmaceutical compositions comprising the derivatives, and to the use thereof as a therapeutical agent, especially as a DPP-IV inhibitor. The definition of each substituent in formula (I) is the same as the definition in the description. 

Hexahydropentaleno derivatives, preparation method and use in medicine thereof

Disclosed are glucopyranosyl derivatives used as sodium dependent glucose cotransporters (SGLTs) inhibitors, intermediates or preparation processes thereof, and pharmaceutical uses thereof, especially glucopyranosyl derivatives represented by Formula (I), or pharmaceutically acceptable salts or all stereoisomers thereof, pharmaceutical compositions containing these derivatives and their uses for treatment of diabetes and diabetes-related diseases. 

Glucopyranosyl derivatives and their uses in medicine

Growing community of inventors

Dongguan, China

Zongyuan Zhang